Development of a Patient-Reported Outcome Questionnaire for Use in Adults with Moderate-to-Severe Plaque Psoriasis: the Psoriasis Symptoms and Signs Diary

Conclusion The PSSD, developed according to the Food and Drug Administration (FDA) PRO Guidance, assesses severity of symptoms and signs commonly associated with plaque PsO. Its measurement properties are currently being evaluated.
Source: Journal of Dermatology and Dermatologic Surgery - Category: Dermatology Source Type: research